Patient Savvy

Cancer Story Deep-Dive

Health EN ↓ 7 episodes

Welcome to the Cancer Story Deep-Dive Podcast by Patient Savvy—a space where courage meets cutting-edge cancer care. Each episode, we share inspiring stories from patients and caregivers, breaking down complex cancer treatments and advances into relatable language. In the 1st season, we take a focused journey into the realm of precision medicine in lung cancer. We’ll explore each biomarker and its corresponding treatment, using real-life patient experiences to bring these discussions to life. Join us for more cancer information: https://patientsavvy.org/

Be sure to visit the podcast's website and support the creator: patientsavvy.org

Author

Patient Savvy

Category

Health

Podcast website

patientsavvy.org

Latest episode

Jun 29, 2025

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Ep 7 - TROP2 Antibody-Drug Conjugate 29.06.2025

This episode covers the basics of TROP2 antibody-drug conjugates (ADCs), a new and promising treatment for lung cancer. We explain how ADCs work differently from chemotherapy and immunotherapy by delivering powerful cancer-killing drugs directly to tumor cells with fewer side effects. The episode highlights TROP2 as a key target in lung cancer and discusses the latest research on TROP2 ADCs, inclu...

Ep 6 - MET-Amplification: Achieving Stable Condition in Extensive Metastatic NSCLC 07.04.2025

In this episode, we explore the groundbreaking impact of targeted therapy for MET amplification in non-small cell lung cancer (NSCLC), focusing on how it has transformed the treatment landscape for patients with advanced, metastatic disease. We’ll delve into the science behind MET amplification, explaining how targeting its overactive signaling can hinder tumor growth and potentially offer new hop...

Ep 5 - RET-Fusion: 9 Years Beyond a 3% Survival Chance of Stage IV NSCLC 07.04.2025

In this episode, we dive into the transformative potential of targeted therapy for RET fusion-positive lung cancer, spotlighting how it has dramatically reshaped outcomes for a young patient with extensive metastatic NSCLC. We’ll break down the science behind the RET pathway, revealing how blocking its abnormal signals can stall tumor growth and even turn stage IV cancer into a more manageable con...

Ep 4 - PD-L1 immunotherapy: Unleashing Your Immune System Against Cancer 17.03.2025

In this episode, we delve into immunotherapy which offers a unique approach compared to targeted therapy. We'll explore how immunotherapy has dramatically shifted the prognosis for lung cancer patients, especially those with advanced disease Our discussion will break down the science behind the PD-1/PD-L1 pathway, explaining how blocking this interaction can reactivate your immune system to co...

Ep 3 - ALK mutation: Keep cancer remain under control regardless of recurrence 17.03.2025

In this episode, we dive into ALK-targeted treatment and its profound impact on the cancer journey of a survivor with extensive metastases. We'll unravel the science behind ALK and illustrate how therapies aimed at this biomarker have revolutionized treatment strategies.  Notably, this approach highlights that targeted therapy remains a viable option even after progression or recurrence follow...

Ep 2 - ROS1 mutation: From extensive metastases to 3 years cancer free and counting 14.03.2025

In this episode, we explore ROS1-targeted treatment and its transformative impact on the cancer journey of a young survivor with extensive metastases. We'll break down the science behind ROS1—a biomarker present in just 1-2% of NSCLC cases—and show how targeting it has reshaped treatment strategies.  Join us as we share an inspiring story of resilience, highlighting both the challenges and breakth...

Ep 1 - EGFR mutation: 25+ years beyond stage 4 NSCLC prognosis 14.03.2025

Welcome to the first episode of our season on precision medicine in lung cancer. Today, we're exploring a pivotal breakthrough from the late 1990s—EGFR-targeted therapy—and its revolutionary impact on stage 4 lung cancer care. In this episode, we highlight the inspiring story of Wells, a cancer survivor for over 25 years, whose life was transformed by this treatment. We’ll break down the science b...

Listen to the Cancer Story Deep-Dive podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.